Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
14.03.2019 21:25:14
|
Johnson & Johnson Ordered To Pay $29 Mln In Latest Talcum Cancer Case
(RTTNews) - Johnson & Johnson was ordered by a California jury to pay $29 million to a woman who claimed that asbestos in the company's talcum powder caused her cancer.
According to Superior Court jury in Oakland, Johnson & Johnson's talc products were responsible for Teresa Leavitt's mesothelioma. The verdict said that the baby powder was a "substantial contributing factor" in her illness.
The New Jersey-based company said it will appeal the verdict. The company faces thousands of similar lawsuits. However, it has denied allegations that its talc causes cancer, saying numerous studies and tests by regulators worldwide have shown that its talc is safe and asbestos-free.
In July last year, a Missouri jury ordered J&J to pay $4.9 billion in a case involving 22 women and their families.
"We respect the legal process and reiterate that jury verdicts are not medical, scientific or regulatory conclusions about a product," J&J said in a statement. "We are disappointed with [Wednesday's] verdict and will pursue an appeal because Johnson's Baby Powder does not contain asbestos or cause cancer."

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
16:03 |
Dow Jones-Handel aktuell: Dow Jones beginnt die Freitagssitzung im Minus (finanzen.at) | |
22.05.25 |
Optimismus in New York: Dow Jones präsentiert sich am Nachmittag fester (finanzen.at) | |
22.05.25 |
NYSE-Handel: Dow Jones mittags mit Gewinnen (finanzen.at) | |
21.05.25 |
Börse New York: Dow Jones verbucht zum Ende des Mittwochshandels Verluste (finanzen.at) | |
21.05.25 |
Schwacher Handel: Dow Jones gibt am Mittwochnachmittag nach (finanzen.at) | |
21.05.25 |
Dow Jones-Handel aktuell: Dow Jones in Rot (finanzen.at) | |
21.05.25 |
Handel in New York: Dow Jones startet mit Verlusten (finanzen.at) | |
20.05.25 |
Anleger in New York halten sich zurück: Dow Jones verbucht schlussendlich Verluste (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 134,60 | -0,59% |
|